Treatments

Two studies published in the past two months provide new clues to when and how the cerebellum contributes to autism.

A team of researchers is trialing a fast approach to autism drug development: simultaneously testing candidates in people and in mice.

Administering a cholesterol drug alongside an antibiotic eases atypical behavior and restores the signaling balance in the brains of people with fragile X syndrome.

Modified stem cells show promise for delivering gene-based therapies to individuals with Angelman syndrome.

Applying sound waves to a mouse’s brain provides a safe way to push molecular probes into the brain to manipulate activity there.

Children with autism tend to have low levels of the hormone vasopressin in their brain, according to the largest study yet to look at the levels.

The drug popularly known as ecstasy may boost sociability through brain circuits distinct from that underlying its ‘high.’

A new protocol enables researchers to rigorously test drugs for Angelman syndrome in mice.

A new type of speech therapy may improve the verbal abilities of children with autism who speak few or no words.